
Afsheen Iqbal MD
Hematologic Oncology, Sarcoma, Thoracic Cancer
Clinical Instructor, Thoracic Oncology Service
136 Mountain View BoulevardBasking Ridge, NJ 07920
Overview of Dr. Iqbal
Dr. Afsheen Iqbal is an oncologist in Basking Ridge, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Overlook Medical Center, and Shore Medical Center. She received her medical degree from Medical University of the Americas and has been in practice 21 years. She is one of 56 doctors at Overlook Medical Center and one of 537 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She also speaks multiple languages, including Hindi, Punjabi, and Urdu. She has more than 10 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2010 - 2013
Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 2006 - 2010
Medical University of the AmericasClass of 2005
Certifications & Licensure
FL State Medical License 2023 - Present
NJ State Medical License 2009 - 2027
NY State Medical License 2010 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2017
Publications & Presentations
PubMed
- Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial.Narek Shaverdian, Michael Offin, Nicolas Toumbacaris, Jasme Lee, Karmelina Charalambous
Nature Communications. 2026-09-07 - A Phase I Study of Cyclical Hypofractionated Palliative Radiation Therapy (Quad Shot) for Central Lung Tumors in Patients With Stage IV Non-Small Cell Lung Cancer: Res...Y Helen Zhang, Afsheen Iqbal, Daphna Gelblum, Jennifer Ma, Ellen Yorke
International Journal of Radiation Oncology, Biology, Physics. 2026-08-18 - Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART).Andreas Rimner, Emily S Lebow, Kelly J Fitzgerald, Leah Kratochvil, Nicolas Toumbacaris
Journal of Clinical Oncology. 2026-07-16
Professional Memberships
- Member
- Member
Other Languages
- Hindi, Punjabi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: